H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 429,954. Minnesota Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Minneapolis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Minneapolis storefront.
Non-Surgical Joint Care Solutions in Minneapolis, MN for clinics & physicians. Non-surgical joint care wit… Compliance support & pricing — contact Hawk Medical.
9.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Population 429,954. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J6 documentation are ready before the first application of non surgical joint care.
National Non-Surgical Joint Care Solutions notes (how the product actually works)9.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 429,954 residents will still mix those payers. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Adult arthritis here is 15.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Minneapolis.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 28.6%; arthritis is 15.2%. That is place-level BRFSS modeling, not a clinic census and not a Minneapolis trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Minneapolis clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Minnesota Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Minneapolis, MN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Minneapolis is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Minneapolis — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Minnesota Part B wound biologics follow this contractor (siblings: IL, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Minneapolis. Useful for joint-program math; still needs a diagnosis and privileging.
No Minneapolis storefront. Joe Bradley is an active practice owner. non surgical joint care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.